Matches in SemOpenAlex for { <https://semopenalex.org/work/W2800553690> ?p ?o ?g. }
- W2800553690 endingPage "491" @default.
- W2800553690 startingPage "486" @default.
- W2800553690 abstract "Aim In vivo pharmacokinetic analysis of [ 44 Sc]Sc-PSMA-617 was used to determine the normal organ-absorbed doses that may result from therapeutic activity of [ 177 Lu]Lu-PSMA-617 and to predict the maximum permissible activity of [ 177 Lu]Lu-PSMA-617 for patients with metastatic castration-resistant prostate carcinoma. Methods Pharmacokinetics of [ 44 Sc]Sc-PSMA-617 was evaluated in 5 patients with metastatic castration-resistant prostate carcinoma using dynamic PET/CT, followed by 3 static PET/CT acquisitions and blood sample collection over 19.5 hours, as well as urine sample collection at 2 time points. Total activity measured in source organs by PET imaging, as well as counts per milliliter measured in blood and urine samples, was decay corrected back to the time of injection using the half-life of 44 Sc. Afterward, forward decay correction using the half-life of 177 Lu was performed, extrapolating the pharmacokinetics of [ 44 Sc]Sc-PSMA-617 to that of [ 177 Lu]Lu-PSMA-617. Source organs residence times and organ-absorbed doses for [ 177 Lu]Lu-PSMA-617 were calculated using OLINDA/EXM software. Bone marrow self-dose was determined with indirect blood-based method, and urinary bladder contents residence time was estimated by trapezoidal approximation. The maximum permissible activity of [ 177 Lu]Lu-PSMA-617 was calculated for each patient considering external beam radiotherapy toxicity limits for radiation absorbed doses to kidneys, bone marrow, salivary glands, and whole body. Results The predicted mean organ-absorbed doses were highest in the kidneys (0.44 mSv/MBq), followed by the salivary glands (0.23 mSv/MBq). The maximum permissible activity was highly variable among patients; limited by whole body–absorbed dose (1 patient), marrow-absorbed dose (1 patient), and kidney-absorbed dose (3 patients). Conclusions [ 44 Sc]Sc-PSMA-617 PET/CT imaging is feasible and allows theoretical extrapolation of the pharmacokinetics of [ 44 Sc]Sc-PSMA-617 to that of [ 177 Lu]Lu-PSMA-617, with the intent of predicting normal organ-absorbed doses and maximum permissible activity in patients scheduled for therapy with [ 177 Lu]Lu-PSMA-617." @default.
- W2800553690 created "2018-05-17" @default.
- W2800553690 creator A5001442023 @default.
- W2800553690 creator A5003646570 @default.
- W2800553690 creator A5003820676 @default.
- W2800553690 creator A5016440729 @default.
- W2800553690 creator A5024581793 @default.
- W2800553690 creator A5037619007 @default.
- W2800553690 creator A5054964394 @default.
- W2800553690 creator A5059816390 @default.
- W2800553690 creator A5060586728 @default.
- W2800553690 creator A5081409254 @default.
- W2800553690 date "2018-07-01" @default.
- W2800553690 modified "2023-10-02" @default.
- W2800553690 title "Prediction of Normal Organ Absorbed Doses for [177Lu]Lu-PSMA-617 Using [44Sc]Sc-PSMA-617 Pharmacokinetics in Patients With Metastatic Castration Resistant Prostate Carcinoma" @default.
- W2800553690 cites W1140456871 @default.
- W2800553690 cites W1497206380 @default.
- W2800553690 cites W1788773500 @default.
- W2800553690 cites W1963061935 @default.
- W2800553690 cites W1970641137 @default.
- W2800553690 cites W2030940240 @default.
- W2800553690 cites W2122716219 @default.
- W2800553690 cites W2302508993 @default.
- W2800553690 cites W2303817381 @default.
- W2800553690 cites W2304896218 @default.
- W2800553690 cites W2415973042 @default.
- W2800553690 cites W2523192478 @default.
- W2800553690 cites W2525124727 @default.
- W2800553690 cites W2578311142 @default.
- W2800553690 cites W2596023559 @default.
- W2800553690 cites W2599305587 @default.
- W2800553690 cites W2612027160 @default.
- W2800553690 cites W2765087867 @default.
- W2800553690 doi "https://doi.org/10.1097/rlu.0000000000002102" @default.
- W2800553690 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/29688951" @default.
- W2800553690 hasPublicationYear "2018" @default.
- W2800553690 type Work @default.
- W2800553690 sameAs 2800553690 @default.
- W2800553690 citedByCount "24" @default.
- W2800553690 countsByYear W28005536902018 @default.
- W2800553690 countsByYear W28005536902019 @default.
- W2800553690 countsByYear W28005536902020 @default.
- W2800553690 countsByYear W28005536902021 @default.
- W2800553690 countsByYear W28005536902022 @default.
- W2800553690 countsByYear W28005536902023 @default.
- W2800553690 crossrefType "journal-article" @default.
- W2800553690 hasAuthorship W2800553690A5001442023 @default.
- W2800553690 hasAuthorship W2800553690A5003646570 @default.
- W2800553690 hasAuthorship W2800553690A5003820676 @default.
- W2800553690 hasAuthorship W2800553690A5016440729 @default.
- W2800553690 hasAuthorship W2800553690A5024581793 @default.
- W2800553690 hasAuthorship W2800553690A5037619007 @default.
- W2800553690 hasAuthorship W2800553690A5054964394 @default.
- W2800553690 hasAuthorship W2800553690A5059816390 @default.
- W2800553690 hasAuthorship W2800553690A5060586728 @default.
- W2800553690 hasAuthorship W2800553690A5081409254 @default.
- W2800553690 hasConcept C112705442 @default.
- W2800553690 hasConcept C121608353 @default.
- W2800553690 hasConcept C126322002 @default.
- W2800553690 hasConcept C126894567 @default.
- W2800553690 hasConcept C151337348 @default.
- W2800553690 hasConcept C2776235491 @default.
- W2800553690 hasConcept C2779256933 @default.
- W2800553690 hasConcept C2780007613 @default.
- W2800553690 hasConcept C2780026642 @default.
- W2800553690 hasConcept C2989005 @default.
- W2800553690 hasConcept C71315377 @default.
- W2800553690 hasConcept C71924100 @default.
- W2800553690 hasConcept C75088862 @default.
- W2800553690 hasConceptScore W2800553690C112705442 @default.
- W2800553690 hasConceptScore W2800553690C121608353 @default.
- W2800553690 hasConceptScore W2800553690C126322002 @default.
- W2800553690 hasConceptScore W2800553690C126894567 @default.
- W2800553690 hasConceptScore W2800553690C151337348 @default.
- W2800553690 hasConceptScore W2800553690C2776235491 @default.
- W2800553690 hasConceptScore W2800553690C2779256933 @default.
- W2800553690 hasConceptScore W2800553690C2780007613 @default.
- W2800553690 hasConceptScore W2800553690C2780026642 @default.
- W2800553690 hasConceptScore W2800553690C2989005 @default.
- W2800553690 hasConceptScore W2800553690C71315377 @default.
- W2800553690 hasConceptScore W2800553690C71924100 @default.
- W2800553690 hasConceptScore W2800553690C75088862 @default.
- W2800553690 hasIssue "7" @default.
- W2800553690 hasLocation W28005536901 @default.
- W2800553690 hasLocation W28005536902 @default.
- W2800553690 hasOpenAccess W2800553690 @default.
- W2800553690 hasPrimaryLocation W28005536901 @default.
- W2800553690 hasRelatedWork W114245097 @default.
- W2800553690 hasRelatedWork W1447876160 @default.
- W2800553690 hasRelatedWork W1923038941 @default.
- W2800553690 hasRelatedWork W1981223719 @default.
- W2800553690 hasRelatedWork W2017183061 @default.
- W2800553690 hasRelatedWork W2227230075 @default.
- W2800553690 hasRelatedWork W2408309885 @default.
- W2800553690 hasRelatedWork W2769953609 @default.
- W2800553690 hasRelatedWork W4255937668 @default.
- W2800553690 hasRelatedWork W2186356445 @default.
- W2800553690 hasVolume "43" @default.